Literature DB >> 3992167

Clindamycin-induced alterations in intestinal microflora-associated characteristics in rats.

B Carlstedt-Duke, B E Gustafsson, T Midtvedt.   

Abstract

Conventional Sprague-Dawley rats were treated with clindamycin, 40 mg/kg/day and 0.04 mg/kg/day, for 5 days. At a dose of 40 mg/kg/day, microflora-associated characteristics (MACs), such as shape, color, and consistency of feces, proteolytic activity, electrophoretic pattern, and cholesterol and bilirubin metabolism were transformed into values like those found in germfree rats: germfree animal characteristics (GACs). The effect on the proteolytic activity lasted longest. It did not disappear until one or two enemas with cecal contents from intact conventional rats were administered. At a dose of 0.04 mg/kg/day, effects on the proteolytic activity and cholesterol metabolism were seen. With the exception of one rat, the effect on proteolytic activity did not disappear until one or two enemas were given. The results indicate that clindamycin, even in very small daily doses, has a profound and long-lasting influence on many intestinal MACs in rats.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3992167     DOI: 10.3109/00365528509089639

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN: 0036-5521            Impact factor:   2.423


  3 in total

1.  Influence of antibiotics on intestinal mucin in healthy subjects.

Authors:  B Carlstedt-Duke; T Høverstad; E Lingaas; K E Norin; H Saxerholt; M Steinbakk; T Midtvedt
Journal:  Eur J Clin Microbiol       Date:  1986-12       Impact factor: 3.267

2.  Establishment of a biochemically active intestinal ecosystem in ex-germfree rats.

Authors:  T Midtvedt; B Carlstedt-Duke; T Höverstad; A C Midtvedt; K E Norin; H Saxerholt
Journal:  Appl Environ Microbiol       Date:  1987-12       Impact factor: 4.792

3.  Increased Pancreatic Protease Activity in Response to Antibiotics Impairs Gut Barrier and Triggers Colitis.

Authors:  Hongsup Yoon; Monika Schaubeck; Ilias Lagkouvardos; Andreas Blesl; Stephanie Heinzlmeir; Hannes Hahne; Thomas Clavel; Suchita Panda; Christina Ludwig; Bernhard Kuster; Chaysavanh Manichanh; Patrizia Kump; Dirk Haller; Gabriele Hörmannsperger
Journal:  Cell Mol Gastroenterol Hepatol       Date:  2018-05-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.